Background. Myocardial reperfusion is associated with calcium overload and cell contracture, mechanisms that may precipitate cell death. In this study, we tested the hypothesis that in vivo inhibition of this contracture could lead to cell preservation in an open-chest large animal model.
R eperfusion of ischemic myocytes can result in complete recovery of structure and function or in cell contracture and massive destruction.1-3 Whether this necrosis occurs in viable cells or in cells already irreversibly damaged is unknown.4-6 However, experimental studies have clearly demonstrated an un-coronary occlusion and coronary reperfusion. The effects on the reperfused myocardium were studied using multiple approaches including characterization of regional wall motion, determination of myocardial water content, quantification of the area at risk, of the area of necrosis, and of the type of histological necrosis, and fractal analysis of infarct geometry.
Methods

Animal Preparation
Adult pigs weighing 30-38 kg were used for the study, according to a protocol previously described.2627 Animals were premedicated with subcutaneous diazepam 5 mg and azaperone 5 mg/kg, anesthetized with intravenous thiopental 300-500 mg, and intubated and mechanically ventilated (Boyle Modular, Medishield, Hatfield, UK). A continuous infusion of thiopental was used to maintain anesthesia throughout the experiment, with the infusion rate adjusted to prevent spontaneous breathing. The right femoral artery and vein were dissected, and SF Tygon catheters were advanced into the inferior vena cava and descending thoracic aorta. A midline sternotomy was performed, and the pericardium was opened. The left anterior descending coronary artery was dissected free as close as possible to the midpoint of its total length and surrounded by a TiCrown No. 2 filament. This filament was passed through a segment of Nelaton tubing to form a snare subsequently used to close and open the artery.
In 26 animals, pairs of ultrasonic crystals 1 mm in diameter were inserted into the inner third of the myocardium. The crystals of each pair were positioned 1-2 cm apart parallel to the short axis of the left ventricle. One pair was implanted in the myocardium to be made ischemic and one pair in the posterolateral wall of the left ventricle irrigated by the left circumflex coronary artery. 28 Sodium heparin 160 IU/kg was then administered, and a Judkins 8F guiding catheter for right coronary artery catheterization was introduced into the main left coronary artery via the right carotid artery. A 4F Rentrop intracoronary catheter was introduced into the guiding catheter and advanced into the distal left anterior descending artery. The guiding catheter was pulled back to the central aorta, and the Rentrop catheter was slowly withdrawn until its tip was positioned a few millimeters distal to the dissection site, taking care that no division branch existed between the tip and the dissection site. This procedure was performed under visual inspection and usually completed within 30 seconds, without changes in the electrocardiogram or in pressure recordings.
This catheter served for the selective intracoronary control and drug infusions in the control animals and in animals with coronary artery occlusion and reperfusion. A Harvard perfusion pump was used to ensure constant delivery of the infusion. In seven animals, coronary artery blood flow was monitored with an electromagnetic flowmeter (MFV 3200 Nikon Koden, Tokyo) implanted immediately distal to the tip of the intracoronary catheter.
Intracoronary Solutions
The intracoronary solutions used for all experiments were prepared 30 minutes before use and kept in a bath at 37°C. They consisted of a solution of Ringer's lactate adjusted to the physiological oncotic pressure of 16 mm Hg by adding 50 g/l of bovine albumin (Boehringer Mannheim Laboratories, Mannheim, FRG) and to a physiological range of free calcium concentration by adding calcium chloride. The actual ionic concentrations and the osmotic pressure measured before every experiment were: Na+, 140.4± 1.4 mM; K', 5.6 +0.1 mM; Ca2+, 1.35+±0.5 mM; osmotic pressure, 276±4 mOsm. The pH was equilibrated at 7 with 0.1 M NaOH. For the intervention group, BDM (Scharlau Laboratories, Madrid) was added to the solution just before use to obtain a concentration of 6 g/l (54.3 mM). The chelating property of BDM resulted in a lowering of free Ca2+ concentration to 0.6+0.1 mM. To rule out an independent effect of this lower concentration, 10 animals (five with the BDM infusion and five with the control infusion) received, in paired observations, the intracoronary solutions at low (0.6 mM) and normal (1.3 mM) free Ca2+ concentration. This resulted in no detectable changes in regional myocardial function. Consequently, no further attempt was made in the study to compensate for the chelating effect of BDM by the addition of Ca2+.
Study Groups and Protocol
Fifty-seven animals were included in three study groups. A first group of 17 pigs underwent all of the surgical procedures including crystal implantation but without the coronary artery occlusion-reperfusion protocol. Seven of these animals served to define the effects of BDM on coronary artery blood flow and 10 its effects on systemic hemodynamics and on regional wall motion compared with a coronary artery occlusion of short duration. For these purposes, animals received sequentially but in a random order for 5 minutes the control solution of albumine and the solution containing BDM. For the coronary artery blood flow study, the infusion rate of the solution was set to 50% of the basal flow to average 11.4±1.2 ml/min; for the hemodynamic study, the rate was set at 9 ml/min. The two infusion periods were separated by an interval of 10-20 minutes; return to baseline was observed in all cases within 3 minutes. Coronary blood flow during the reactive hyperemia after a 20-second coronary occlusion was also recorded. In four animals that received the BDM perfused last, the rate of infusion was decreased to 6 ml/min for 10 minutes and 3 ml/min for an additional 20 minutes. A 5-minute coronary occlusion was performed after this infusion to compare the regional myocardial changes induced by the drug alone with the changes induced by ischemia. The study was then terminated.
The 40 other pigs were included in a protocol of 51 minutes of left anterior descending coronary artery occlusion followed by reperfusion. They were randomized after the coronary occlusion had been performed to receive either the control solution or the solution containing BDM. The intracoronary infusion was initiated 3 minutes before reperfusion and maintained for 33 minutes during reperfusion. The initial infusion rate was 9 ml/min for 6 minutes (3 minutes during occlusion and 3 minutes during reperfusion); the rate was then progressively tapered to 6 ml/min for 10 minutes and 3 ml/min for 20 minutes. minutes after the initiation of the intracoronary infusion, and during early and late reperfusion. Early measurements during reperfusion were obtained after 3 minutes, when the intracoronary infusion rate was high, and the late measurement after 30 minutes, when the infusion rate was lowest. Six of these 16 animals were used for the study of myocardial water content. In these animals, the left anterior descending coronary artery was reoccluded after the late measurement, and the area at risk was delineated with fluorescein injected into the left atrium. The hearts were then excised and immersed in cold saline until arrested.
The 24 other animals in the occlusion-reperfusion and intracoronary infusion protocol had no crystals implanted and were used for the study of infarct size and geometry. These animals also had 25,000 99mTc-labeled microspheres (0.075 mCi, [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] ,um in size) injected with the 27 ml of solution infused during the occlusion period. The sternotomy was closed in these animals 40 minutes after reperfusion, leaving in place a pleuropericardial drain. All catheters were then withdrawn. Twenty hours after this initial procedure, animals were again premedicated, anesthetized, and ventilated by the same procedure as for the initial surgery. The left anterior descending coronary artery was reoccluded, and 5 ml of 10% fluorescein was injected into the left atrium. The heart was excised 5 seconds later and immersed in cold saline. Patency of the ostium of the left main coronary artery and the proximal segment of the circumflex and of the left anterior descending coronary artery were assessed. Two animals in this group died overnight and six had reocclusion of the left anterior descending coronary artery. These animals were evenly distributed in the two study groups and were excluded from further histochemical and histological analysis, leaving for analysis a total of eight pigs in the control infusion group and eight in the BDM group.
Study Monitoring
Hematocrit and serum content of Na+, K+, Ca 2+ glucose, and creatinine measured at the beginning of each experiment showed no significant deviations. Arterial pH, Pao2, and PaCO2 were closely monitored to adjust the ventilatory parameters to maintain normal blood gases. Aortic blood pressure was continuously monitored with a crystal quartz transducer (Hewlett Packard 1290A); the two ultrasonic segment length signals were monitored with a Schusler dimension gauge and recorded along with lead II of the electrocardiogram on a Hewlett Packard 78308A polygraph (Waltham, Mass.) and Siemens Elema 12 recorder (Erlangen, FRG) at a paper speed of 10 mm/sec. Recordings at 50 and 100 mm/sec were also obtained at a selected time before occlusion, before the initiation of the intracoronary infusion, before reperfusion, and 3, 5, and 30 minutes later. Calibration points were periodically verified to correct any drift that could have occurred in the signal.
Segment Length Measurements
Measurements were made at fast paper speed recordings on an average of 10 beats. Respiratory variations were minimal in this preparation. End-diastolic and end-systolic lengths could be easily identified on the crystal signals before, during, and after coronary occlusion. End diastole was identified on the crystal tracing of the control segment as the point of initial shortening during isovolumic systole just after the end of the A wave. End systole coincided with a break in the shortening curve corresponding to the closure of the aortic valve at onset of isovolumic relaxation. In the control state in the two segments and in the control segment during coronary occlusion, end systole usually coincided with the point of minimal length of the signal. During In the first step of analysis, the gray level contrasts of each image were expanded and standardized to a new 258 gray level scale format, assigning 0 to the darkest gray (black) and 258 to the whitest one. The operator was then requested to trace a line crossing the background, the normal myocardium, and the infarct area. The computer displayed the numerical values for the gray levels of all points across this line. This procedure was repeated several times to allow exact detection of changes in light intensity between normal and necrotic myocardium and between normal myocardium and background. At each procedure, the setting for detection was derived using receiver operating curves for maximum sensitivity and minimal data dispersion. The mean of the values calculated served to define the two numerical thresholds that were used for edge delimitation of the myocardium from the background and of the area of necrosis from normal myocardium. The original image and the image with the automatically generated contours were displayed simultaneously on the screen. The operator was then allowed to reject a particular section that could represent artifacts such as a fragment of epicardial tissue or chordae tendinae. Contours corresponding to the right ventricular wall were also disregarded. In the rare instances in which the automatically generated contours of the area of necrosis and of the borders of the myocardium touched each other, the operator could identify them as two separated contours by using the mouse. In no case was it possible to modify or redraw an automatically generated contour; although it allowed removal of artifacts, the system would not permit operator modification of contours.
In the final step of the analysis, the program calculated from the generated contours several indexes describing the geometry of the infarct area. These included the number of patches of necrosis, a contour index, and a fractal index. Patches of necrosis were defined as completely separate islands of necrotic tissue not touching each other. The contour index reflected the relation between the outer minimal contour of a patch of necrosis (P out) and its area (A) with the formula (P out)2/4irA. The fractal index was used to define the relation between the perimeter (P) of a patch and the square root of its area (A) with the formula P/VA. The fractal index was calculated from the main patch of necrosis and both the fractal and contour indexes from all patches of one slice by pooling the patches together. The automatically generated areas and contours, the generated indexes, the thresholds selected for edge detection, and all other intermediary steps used in image processing were stored in a computer file. The thresholds generated to discriminate normal and necrotic tissue were similar in the control and BDM groups.
Statistical Analysis
All analyses including the hemodynamic and regional function data, water content, infarct size and area at risk measurements, and geometry of the infarcts were performed blindly with the investigators unaware of the treatment allocation.
Statistical comparisons between two groups were performed by Student's t test for independent samples after the data had been assessed for normal distribution; when a normal distribution was not present, nonparametric statistics were performed using the Wilcoxon test for independent observations. Changes in regional myocardial blood flow and in regional function in the same animal with various measurements over time were assessed using an analysis of variance and Student's t tests for paired data. The relation between the ratio of infarct size and area at risk was evaluated by linear regression analysis. Intergroup differences in frequency were assessed by the Fisher's exact test. A probability value of less than 0.05 was considered significant. Values are expressed as mean + 1 SEM.
Results
Hemodynamic Effects
The hemodynamic effects of the intracoronary infusion of BDM, in the protocol with no coronary occlusion and in the protocol with coronary occlusion and reperfusion, are described in Tables 1 and 2 faster with BDM (Table 1) . Similarly, systolic blood pressure was unchanged with albumin but decreased with the active drug. Coronary occlusion without infusion in the same animals resulted in changes in heart rate and systolic blood pressure similar to the changes observed with BDM ( Table 1) . As shown in Table 2 , the hemodynamic changes during coronary occlusion and reperfusion were similar in the control and BDM infusion groups.
Regional Myocardial Function
The changes in regional myocardial function after the intracoronary infusions with and without BDM and with coronary occlusion without intracoronary infusion are provided in Table 1 and illustrated in Figure 1 . Figure 2 shows a typical example. The control albumin infusion resulted in no modifications in end-diastolic length or systolic shortening of the control segment or of the segment distal to the selective infusion. BDM infusion resulted in no significant changes in the control noninfused segment but completely suppressed systolic shortening and induced paradoxical systolic expansion of the infused segment with a 10% increase in end-diastolic length. These changes with BDM were similar to the changes induced by coronary occlusion in the same animals ( Figure 1 ). The effects of BDM began immediately after the initiation of the infusion and were fully established after 1 minute; they were transient with a return to baseline values within 5 minutes after discontinuation of the infusion (Table 1) . A clear doseresponse curve was present (Figures 3 and 4) . When the rate of infusion was decreased from 9 to 6 ml/min, systolic shortening reappeared but only at 43% of control values. Decreasing the infusion rate to 3 ml/min was associated with a further 21% improvement in shortening.
The ultrasonic segment length measurements obtained in the study groups with coronary occlusion and reperfusion are provided in Table 2 and in Figure 5 . End-diastolic length and systolic shortening of the control nonischemic segment showed no significant changes with any of the interventions. End-diastolic length of the ischemic segment increased during the occlusion as systolic expansion appeared. The infusion of BDM during occlusion had no effect on wall motion. During early reperfusion, however, when the maximal dose was being infused, end-diastolic length decreased 75% more than with the control infusion, with a striking increase in systolic bulging. Maximal Figure 6 .
Coronary Blood Flow
Mean coronary blood flow measured with the electromagnetic flowmeter was unchanged with the control infusion but increased from 29.6+4.6 to 55.8+9. 4 (Figure 7 ).
Transmural Distribution of the Intracoronary Infusate
Radiolabeled microspheres injected with the intracoronary infusion during occlusion distributed almost exclusively within the area at risk, with only 0.004±0.002% of the total activity detected outside in the control myocardium. The transmural distribution was uneven, with a preferential flow to the outer third of the left ventricular wall, which received half the flow in the control group. In the BDM group, this preferential flow was greater, 75% of total flow to ischemic area (p<0.02) (Figure 8 ).
Myocardial Water Content
Water content measured in multiple myocardial fragments from the area at risk showed a narrow range of variation, without any significant difference between control and treated animals; water content was 540±9 ml per 100 g dry weight tissue in the control group and 557±18 in the group with BDM (NS FIGURE 6 . Typical examples of recordings obtained in the occlusion-reperfusion protocol with control and 2,3-butanedione monoxime (BDM) solutions infused during the last 3 minutes of occlusion and during reperfusion. Early reperfusion data were obtained after 3 minutes of reperfusion at maximal intracoronary infusion rate. Late data were obtained after 30 minutes, when infusion rate was minimal after step-down protocol of intracoronary infusion. The most striking changes are a decrease with BDM in end-diastolic length of the ischemic segment during early reperfusion, with an increase in systolic expansion.
Infarct Size and Area at Risk
The individual data for area at risk, infarct size, and their ratio are provided in Table 3 . Area at risk expressed in grams of tissue was 22% greater in the BDM group (p=0.16). Despite the greater amount of tissue at jeopardy, infarct size was 16% smaller and involvement of left ventricular mass was 21% less, for a 31% reduction in the ratio infarct size/area at risk (p<0.02).
The correlation coefficient between infarct size and area at risk was 0.99 (p<0.001) in the control animals ( Figure 9 ). This correlation was modified in the treatment group, with all infarct sizes smaller than predicted from the area at risk and a wider dispersion of the data points (r=0.77, p=0.02). Area at risk (g) FIGURE 9 . Graph shows correlation between area at risk and infarct size. In the control intracoronary infusion group, a close linear relation is observed (r=O.99). In the 2,3-butanedione monoxime (BDM) group, all infarcts were smaller than predicted from the area at risk, with a wider dispersion of the data points.
61±13% of the total area of necrosis in the control group but for only 24+4% in the BDM group (p<0.02) ( Table 4 ). This area was reduced from 52.8+8.3 to 23.3 ±7.3 mm2 (NS) in the epicardial half and from 52.6±9 to 15.9±7.7 mm2 in the endocardial half (p=0.03). The relative transmural distribution of contraction band necrosis was not, however, modified, with respectively 54±5% and 61±10% occupying the outer myocardial half (NS). The drawings of all 12 hearts studied showing the relative distribution of contraction band and coagulation necrosis are shown in Figure 10 .
Infarct Geometry Infarcts in animals treated with BDM showed a strikingly different geometry compared with infarcts in control animals. This was apparent even by visual inspection, as illustrated in Figures 11 and 12 , which show typical examples of infarcts from both study groups. The quantitative analysis of infarct geometry showed statistically significant differences between the two study groups for all parameters (Table 5) . Welldefined patches of necrosis were four times as frequent BDM Infusion in the treated animals (6.1+2.1 versus 1.57+0.42, p<0.05); more than two patches of necrosis were present in only one of the eight control animals and in five of the eight treated animals. The fractal index of the major patch of necrosis and the fractal and contour indexes of all patches considered together were all significantly greater in the BDM group (Table 5) . Discussion This study documents that an intracoronary infusion of BDM in vivo in a large animal model results in a selective inhibition of segmental wall shortening despite an increase in coronary blood flow, creating regional dyskinesia in the absence of ischemia. This BDMinduced inhibition of active shortening during coronary occlusion and reperfusion resulted in a reduction of infarct size, with striking diminutions in the extent of contraction band necrosis and in the coalescence of the infarct. These effects were not associated with changes of systemic hemodynamics, wall motion of the nonischemic myocardium, or early water content of the reperfused myocardium. The distinctive geometry of the infarct, with patches of necrosis and anfractuous edges, suggests an interference with the wave front progression of cell necrosis, supporting a major role of cell contracture in reperfusion-induced necrosis and cell-to-cell progression of myocardial necrosis.
Regional Dyskinesia in the Absence of Ischemia
The selective intracoronary infusion of BDM in the absence of myocardial ischemia resulted in increased regional end-diastolic length, loss of active systolic shortening, and paradoxical systolic expansion despite an increase in coronary blood flow. These changes were similar to those observed after coronary occlusion in the same animals, with the site of occlusion corresponding to the site of the intracoronary infusion. In contrast to bulging induced by ischemia, no cyanosis accompanied the contraction abnormality. As during coronary occlusion, however, the "red" dyskinesia developed within seconds after the initiation of the infusion, persisted throughout the infusion, and reversed rapidly and com-A WB~~~~~D pletely after discontinuation of the drug. BDM inhibition was dose related: decreasing the dose resulted in increased shortening. No such changes were observed when the intracoronary infusion did not contain BDM, and BDM had no effect on the control noninfused myocardium. The infusion was associated with a slight acceleration in heart rate and a slight decrease in systolic pressure, similar to the changes observed during coronary occlusion. These minor hemodynamic changes are probably the consequences of a loss of regional myocardial function rather than a direct drug effect. The rationale behind the use of these indexes and of a fractal structure to describe infarcts in this study relies on the pattern of growth of infarcts with spatial correlation and continuity in their margins.3839 A fractal dimension, however complex it might be, possesses a characteristic form that remains constant over a magnitude of scales and that can be described independently of the resolution power of the method of analysis used. Fractal structures are present in nature; a classic example is the coastline of a continent; a beautiful example is a larch.
The computer analyses allowed quantification of shape and enhanced resolution compared with visual inspection. However, the overall resolution of the method remains low, and the technique does not reflect geometric changes occurring at the cellular level. Nevertheless, the fractal theory predicts that the absolute value of the perimeter of a fractal area increases in relation to the power of resolution of the measurement method but that the fractal dimension remains constant.38 Thus, changes in shape assessed by methods with relatively low resolution power could presumably reflect changes at the microscopic geometry of the area of necrosis.
This unique geometry of infarcts reperfused with BDM, when combined with the striking reduction in contraction band necrosis and with the known effect of the drug in reperfused isolated hearts, permits some insight into the possible mechanisms associated with cell damage during reperfusion.
Calcium Paradox, Calcium Overload, Cell Death, and Progression of Necrosis Reperfusion with a calcium-containing solution after calcium-free perfusion8 or after ischemia7 is associated with an early massive influx of calcium into the cell up to a 10-fold increase within 10 minutes of reperfusion. This calcium paradox and calcium overload typically result in irreversible contracture.9 The contracture, though tolerated in isolated cultured cells with no external mechanical constraints,640 is associated in vivo with massive cell disruption. Indeed, hypoxic cardiomyocytes become increasingly fragile41 with weakened intercalated disks910 and may not tolerate the impact of mechanical interaction1"'15'16; this may represent a major mechanism explaining cell death and also progression of cell necrosis. This cell-to-cell interaction may explain the wave front phenomenon observed in the progression of necrosis.'6 This mechanism may be operative despite self-protection of the cell against increased intracellular concentrations of Ca2' and of other ions by a mechanism facilitating the functional conductance at the gap junctions.42 This protective process, however, will not prevent mechanical interaction; a strong adjacent sarcolemma that could withstand transmitted mechanical stress would be required to stop the directional spatial progression of cell necrosis.
Possible other mechanisms explaining the reduction in infarct size in this study could be an increase in collateral blood flow or the redistribution of transmural blood flow affecting the distribution of activated blood cells, oxygen free radicals, or of complement during reperfusion. The collateral circulation is virtually absent in the pig heart,43 and the preferential flow distribution observed in this study toward the subepicardium was likely the consequence of a direct coronary vasodilatory effect of BDM. Despite this preferential subepicardial distribution, subendocardial flow remained substantial and no differences existed in the transmural distribution of the infarcts and of the areas of contraction band and coagulation necrosis. Conversely, interventions with agents acting on white cells and on free radicals have controversial effects on infarct size and, more specifically, have not been reported to fundamentally modify infarct geometry.
The observed decrease in infarct size accompanied by the specific geometric pattern of very anfractuous infarcts and the important reduction of contraction band necrosis with BDM suggests that the drug may interfere with cell-to-cell progression of necrosis. Reduction of contracture with BDM could indeed reduce mechanical stress, prevent disruption of some of the cells, and halve progression of necrosis. Alternatively, promoting contracture, as demonstrated with caffeine injected into the calcium-free perfused heart, results in contraction bands, wide separation of cells at intercalated disks, and sarcolemmal membrane injury.44
